Delivery Order SPE2DB22D1106-SPE2DB23FEEJ2

Award Date 4/19/23
Potential Completion Date 4/20/23
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,121.70, was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,560,091 units of Metformin HCL ER 500 mg tablets, a medication used to treat diabetes. The contract has a period of performance through March 1, 2023 and is a firm fixed-price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,751.90 delivery order contract is for the supply of Metformin HCL ER 500 mg tablets, a common prescription medication used to treat diabetes. The contract is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,345.68 firm fixed price delivery order is for the supply of Metformin HCL ER 500 mg tablets, a medication used to treat diabetes. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, identified as SPE2DB20D3103|SPE2DB25FM4X5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,904.31 Firm Fixed Price Delivery Order covers the supply of METFORMIN HCL ER 500 MG TABLET 500S, a generic medication used to treat diabetes. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,142.86 contract is for the delivery of 4,560,716,131 units of Metformin HCL ER 500 mg tablets to support medical needs. The contract has a firm fixed price and an ultimate completion date of April 26, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,531.50 firm fixed-price delivery order is for the supply of Metformin HCL 1,000 mg tablets, a common medication for diabetes management. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,421.61 firm-fixed-price delivery order is for the supply of Metformin HCL ER 500 mg tablets to support federal healthcare programs. The award is not associated with a set-aside and represents a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999, which serves as a primary vehicle for...
This federal contract award, number SPE2DB22D1106|SPE2DB25FDWP3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,032.80 fixed-price delivery order is for 180 tablets of Metformin HCL ER 500 mg, a medication used to treat diabetes. The award is not designated as a set-aside contract. It is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,141.47 firm-fixed-price delivery order covers the supply of 4,559,445,920 tablets of Metformin HCl ER 500 mg, a medication used to treat diabetes. The award has an ultimate completion date of December 23, 2022 and was made on December 22, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,652.16 Firm Fixed Price Delivery Order is for the supply of 4,565,927,639 units of Metformin HCL 500 mg tablets, a common medication used to treat diabetes. The contract has an ultimate completion date of September 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB23FEEJ2
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,702.56 Firm Fixed Price delivery order is for the supply of Metformin HCL ER 500 mg tablets, a medication used to treat type 2 diabetes.

The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition.

Generated 5/9/25, 9:47 AM